Recently, an existing drug called ubrogepant went through phase 3 clinical trials demonstrating that it can also be used to stop migraine headaches before they even start and could help with ...

CMS Monday proposed a 2026 physician payment rule that proposes a new payment model focused on improving chronic disease management.

"Our results, based on 1.2 million Danish children and a study period covering 24 years, provide robust evidence supporting ...